AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock
With a mortality rate of 20-30% for sepsis and 30-50% for septic shock in developed countries, sepsis represents an enormous public health burden and is responsible for almost 20% of all deaths worldwide Enibarcimab has the potential to become the first …